These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34402912)

  • 21. A clonal expression biomarker associates with lung cancer mortality.
    Biswas D; Birkbak NJ; Rosenthal R; Hiley CT; Lim EL; Papp K; Boeing S; Krzystanek M; Djureinovic D; La Fleur L; Greco M; Döme B; Fillinger J; Brunnström H; Wu Y; Moore DA; Skrzypski M; Abbosh C; Litchfield K; Al Bakir M; Watkins TBK; Veeriah S; Wilson GA; Jamal-Hanjani M; Moldvay J; Botling J; Chinnaiyan AM; Micke P; Hackshaw A; Bartek J; Csabai I; Szallasi Z; Herrero J; McGranahan N; Swanton C;
    Nat Med; 2019 Oct; 25(10):1540-1548. PubMed ID: 31591602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
    Ai H; Song D; Wang X
    Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 28. An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles.
    Li M; Zhang Z; Li L; Wang X
    Commun Biol; 2020 Sep; 3(1):505. PubMed ID: 32917965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Infiltration of Immune Cells Driven by Tumor Heterogeneity Reveals Two Immune Subtypes in Lung Adenocarcinoma.
    Wang L; Song Y; Bai J; Sun W; Yu J; Cai M; Fu S
    Front Genet; 2022; 13():924781. PubMed ID: 35860464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
    Mony JT; Schuchert MJ
    Front Immunol; 2018; 9():2298. PubMed ID: 30374348
    [No Abstract]   [Full Text] [Related]  

  • 31. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.
    Zhang J; Fujimoto J; Zhang J; Wedge DC; Song X; Zhang J; Seth S; Chow CW; Cao Y; Gumbs C; Gold KA; Kalhor N; Little L; Mahadeshwar H; Moran C; Protopopov A; Sun H; Tang J; Wu X; Ye Y; William WN; Lee JJ; Heymach JV; Hong WK; Swisher S; Wistuba II; Futreal PA
    Science; 2014 Oct; 346(6206):256-9. PubMed ID: 25301631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.
    Wang Y; Xu J; Lan T; Zhou C; Liu P
    Cancer Med; 2023 Dec; 12(24):21651-21665. PubMed ID: 37965778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
    Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
    Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCR repertoire intratumor heterogeneity of CD4
    Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
    Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
    Saeki S; Kumegawa K; Takahashi Y; Yang L; Osako T; Yasen M; Otsuji K; Miyata K; Yamakawa K; Suzuka J; Sakimoto Y; Ozaki Y; Takano T; Sano T; Noda T; Ohno S; Yao R; Ueno T; Maruyama R
    Breast Cancer Res; 2023 Feb; 25(1):21. PubMed ID: 36810117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.